Results 131 to 140 of about 17,506 (176)

Development of nanoemulsion for efficient brain parenteral delivery of cefuroxime: designs, characterizations, and pharmacokinetics

open access: yesInternational Journal of Nanomedicine, 2018
Siti Norhawani Harun,1 Syafinaz Amin Nordin,2 Siti Salwa Abd Gani,3,4 Ahmad Fuad Shamsuddin,5,6 Mahiran Basri,7 Hamidon Bin Basri1 1Department of Medicine, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia ...
Harun SN   +5 more
doaj  

Extended Spectrum beta-Lactamase Bacteria and Multidrug Resistance in Jordan are Predicted Using a New Machine-Learning system

open access: yesInfection and Drug Resistance
Enas M Al-Khlifeh,1 Ibrahim S Alkhazi,2 Majed Abdullah Alrowaily,3 Mansoor Alghamdi,4 Malek Alrashidi,4 Ahmad S Tarawneh,5 Ibraheem M Alkhawaldeh,6 Ahmad B Hassanat5 1Department of Medical Laboratory Science, Al-Balqa Applied University, Al-salt, 19117 ...
Al-Khlifeh EM   +7 more
doaj  

Outcome of bioprosthetic valve replacement in dogs with tricuspid valve dysplasia [PDF]

open access: yes, 2017
Adin   +15 more
core   +2 more sources

Dangerous creatures of the Maltese sea : injuries and treatment : part 2 [PDF]

open access: yes, 2012
This is the second of a two-part article intended to give information about different organisms which inhabit the Maltese sea and which are potentially harmful.
Sammut, David James
core   +1 more source

Consumption of antibiotics at St Luke’s Hospital : a critical factor behind the local prevalence of antimicrobial resistance? [PDF]

open access: yes, 2006
The intensity of antibiotic use in hospital settings is recognised as possibly the most important factor for the selection of antimicrobial resistance. Hospitals are therefore being encouraged to undertake surveillance and benchmarking of antimicrobial ...
Borg, Michael Angelo, Zarb, Peter
core  

Guidelines by an ad hoc European committe for elective chronic peritoneal dialysis in pediatric patients [PDF]

open access: yes, 2001
ALONSO, A   +12 more
core  

Cefuroxime axetil

International Journal of Antimicrobial Agents, 1994
Cefuroxime is the first commercially-available second-generation cephalosporine to be widely used in therapy; it is a semi-synthetic cephalosporin obtained from the 7-cephalosporanic acid nucleus of cephalosporin C. Cefuroxime axetil is the acetoxyethyl ester of cefuroxime.
exaly   +3 more sources

Home - About - Disclaimer - Privacy